Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona C Kimberley

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cell Research|November 13, 2004
Following a TRAIL: update on a ligand and its five receptorsFiona C Kimberley, Gavin R Screaton
Journal of Cellular Physiology|August 30, 2008
"APRIL hath put a spring of youth in everything": Relevance of APRIL for survivalFiona C Kimberley, Michael Hahne, Jan Paul Medema
Molecular Immunology|August 4, 2006
Alternative roles for CD59Fiona C Kimberley, Baalasubramanian Sivasankar, B Paul Morgan
Results and Problems in Cell Differentiation|January 15, 2009
APRIL in B-cell malignancies and autoimmunityFiona C Kimberley, Jan Paul Medema, Michael Hahne
Arthritis Research & Therapy|August 2, 2007
Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndromeFiona C Kimberley, Adrian A Lobito, Richard M Siegel, et al.
Trends in Molecular Medicine|July 5, 2011
Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving diseaseAdrian A Lobito, Tanit L Gabriel, Jan Paul Medema, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 15, 2009
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linkingFiona C Kimberley, Liesbeth van Bostelen, Katherine Cameron, et al.
The Journal of Biological Chemistry|September 11, 2012
The design and characterization of receptor-selective APRIL variantsFiona C Kimberley, Almer M van der Sloot, Marco Guadagnoli, et al.
Blood|May 6, 2011
Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomasMarco Guadagnoli, Fiona C Kimberley, Uyen Phan, et al.
Cell Research|July 1, 2005
Expression of TRAIL and TRAIL receptors in normal and malignant tissuesRaymond A Daniels, Helen Turley, Fiona C Kimberley, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cell Research|November 13, 2004
Following a TRAIL: update on a ligand and its five receptorsFiona C Kimberley, Gavin R Screaton
Journal of Cellular Physiology|August 30, 2008
"APRIL hath put a spring of youth in everything": Relevance of APRIL for survivalFiona C Kimberley, Michael Hahne, Jan Paul Medema
Molecular Immunology|August 4, 2006
Alternative roles for CD59Fiona C Kimberley, Baalasubramanian Sivasankar, B Paul Morgan
Results and Problems in Cell Differentiation|January 15, 2009
APRIL in B-cell malignancies and autoimmunityFiona C Kimberley, Jan Paul Medema, Michael Hahne
Arthritis Research & Therapy|August 2, 2007
Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndromeFiona C Kimberley, Adrian A Lobito, Richard M Siegel, et al.
Trends in Molecular Medicine|July 5, 2011
Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving diseaseAdrian A Lobito, Tanit L Gabriel, Jan Paul Medema, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 15, 2009
The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linkingFiona C Kimberley, Liesbeth van Bostelen, Katherine Cameron, et al.
The Journal of Biological Chemistry|September 11, 2012
The design and characterization of receptor-selective APRIL variantsFiona C Kimberley, Almer M van der Sloot, Marco Guadagnoli, et al.
Blood|May 6, 2011
Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomasMarco Guadagnoli, Fiona C Kimberley, Uyen Phan, et al.
Cell Research|July 1, 2005
Expression of TRAIL and TRAIL receptors in normal and malignant tissuesRaymond A Daniels, Helen Turley, Fiona C Kimberley, et al.
Pageof 2